These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 9588577

  • 1. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S, Wang XM, Chia D, Ozawa M, Zhong HP, Hirata M, Terasaki PI, Kobashigawa JA.
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [Abstract] [Full Text] [Related]

  • 2. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.
    Kobashigawa JA, Moriguchi JD, Laks H, Wener L, Hage A, Hamilton MA, Cogert G, Marquez A, Vassilakis ME, Patel J, Yeatman L.
    J Heart Lung Transplant; 2005 Nov; 24(11):1736-40. PubMed ID: 16297773
    [Abstract] [Full Text] [Related]

  • 3. Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: lipid lowering and immunosuppression.
    Katznelson S, Kobashigawa JA.
    Kidney Int Suppl; 1995 Dec; 52():S112-5. PubMed ID: 8587272
    [Abstract] [Full Text] [Related]

  • 4. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
    Stojanovic I, Vrtovec B, Radovancevic B, Radovancevic R, Yazdanbakhsh AP, Thomas CD, Frazier OH.
    J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of pravastatin on outcomes after cardiac transplantation.
    Kobashigawa JA, Katznelson S, Laks H, Johnson JA, Yeatman L, Wang XM, Chia D, Terasaki PI, Sabad A, Cogert GA.
    N Engl J Med; 1995 Sep 07; 333(10):621-7. PubMed ID: 7637722
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reassuring effect of pravastatin on natural killer cell activity in stable renal transplant patients.
    Vaessen LM, van Miert PP, van Gelder T, Ijzermans JN, Weimar W.
    Transplantation; 2001 Apr 27; 71(8):1175-9. PubMed ID: 11374422
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
    Haeryfar SM, Lan Z, Leon-Ponte M, Duffy KR, Ge W, Liu W, Mele T, Garcia B, Wang H.
    Transplantation; 2008 Aug 15; 86(3):460-8. PubMed ID: 18698251
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of pravastatin on the function of dendritic cells in patients with coronary heart disease.
    Li X, Liu C, Cui J, Dong M, Peng CH, Li QS, Cheng JL, Jiang SL, Tian Y.
    Basic Clin Pharmacol Toxicol; 2009 Feb 15; 104(2):101-6. PubMed ID: 19143751
    [Abstract] [Full Text] [Related]

  • 18. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec 15; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Statins benefit outcomes of renal transplant recipients on a sirolimus-cyclosporine regimen.
    Lisik W, Schoenberg L, Lasky RE, Kahan BD.
    Transplant Proc; 2007 Dec 15; 39(10):3086-92. PubMed ID: 18089328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.